Birdwatch Note
2024-08-01 18:26:38 UTC - NOT_MISLEADING
🔴NNN🔴 Imane Khelif's participation in women's boxing is controversial due to her XY chromosomes and high testosterone levels compared to other Participans. This disorder of sex development give her physical advantages over typical female competitors, raising fairness concerns.
Written by 2F017001BA2628684B71EDDAE2A76CD526ECBD77C987A1720CB838123E66F2CE
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1819051572854202529
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1819077296097317039
- noteId - 1819077296097317039
- participantId -
- noteAuthorParticipantId - 2F017001BA2628684B71EDDAE2A76CD526ECBD77C987A1720CB838123E66F2CE
- createdAtMillis - 1722536798868
- tweetId - 1819051572854202529
- classification - NOT_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 1
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- 🔴NNN🔴 Imane Khelif's participation in women's boxing is controversial due to her XY chromosomes and high testosterone levels compared to other Participans. This disorder of sex development give her physical advantages over typical female competitors, raising fairness concerns.
Note Ratings
| rated at | rated by | |
| 2024-08-02 10:29:23 -0500 | Rating Details | |
| 2024-08-02 08:00:48 -0500 | Rating Details | |
| 2024-08-02 02:53:20 -0500 | Rating Details | |
| 2024-08-02 01:03:37 -0500 | Rating Details | |
| 2024-08-01 23:50:22 -0500 | Rating Details | |
| 2024-08-01 20:37:16 -0500 | Rating Details | |
| 2024-08-01 20:00:26 -0500 | Rating Details | |
| 2024-08-01 17:01:28 -0500 | Rating Details | |
| 2024-08-01 16:42:45 -0500 | Rating Details | |
| 2024-08-01 16:01:02 -0500 | Rating Details | |
| 2024-08-01 15:24:35 -0500 | Rating Details | |
| 2024-08-01 15:23:56 -0500 | Rating Details | |
| 2024-08-01 15:04:10 -0500 | Rating Details | |
| 2024-08-01 14:31:51 -0500 | Rating Details | |
| 2024-08-01 14:29:40 -0500 | Rating Details | |
| 2024-08-01 14:26:16 -0500 | Rating Details | |
| 2024-08-01 14:25:41 -0500 | Rating Details | |
| 2024-08-01 14:22:31 -0500 | Rating Details | |
| 2024-08-01 14:19:45 -0500 | Rating Details | |
| 2024-08-01 14:12:59 -0500 | Rating Details | |
| 2024-08-01 14:07:53 -0500 | Rating Details | |
| 2024-08-01 14:06:51 -0500 | Rating Details | |
| 2024-08-01 13:47:38 -0500 | Rating Details | |
| 2024-08-01 13:40:18 -0500 | Rating Details | |
| 2024-08-01 13:39:04 -0500 | Rating Details | |
| 2024-08-01 13:33:44 -0500 | Rating Details | |
| 2024-08-01 13:29:50 -0500 | Rating Details | |
| 2024-08-01 22:15:03 -0500 | Rating Details |